Antja-Voy Hartley 

***

is a postdoctoral research fellow at Dana-Farber Cancer Institute/Harvard Medical School where she studies novel combinatorial treatments to overcome drug resistance in non-small cell lung cancers. She recently graduated from Indiana University School of Medicine with a Ph.D. in Pharmacology. She has been actively engaged in science outreach, mentoring elementary school aged kids and participating in programs that encourage minorities to persist in STEM fields. She is an avid science writer, authoring and co-authoring more than 15 scientific papers in a range of topics related to cancer and epigenetics. She enjoys traveling, the great outdoors and writing and making music.